Hot line:010-83057670
ENGood News | Leadingpharm Wins Honors Such as "Top 50 R&D Companies" and "Law-Abiding and Integrity Enterprises" in the Pharmaceutical Industry for 2023-2024!
Release time：2024-11-06
From November 4 to 6, 2024, the 3rd Taishan Pharmaceutical Forum and the "2023-2024 Pharmaceutical Industry Information Conference" were successfully held in Jinan, Shandong. At this forum, Leadingpharm, with its outstanding R&D strength and industry influence, won honors such as "Top 50 R&D Companies" and "Law-Abiding and Integrity Enterprises" in the pharmaceutical industry for 2023-2024.
The Taishan Pharmaceutical Forum, as an authoritative event in the pharmaceutical industry, aims to gather industry elites to discuss the development trends and future opportunities of the pharmaceutical and health industry. With the theme of "All-Industry · Big Platform · Deep Integration · Common Development", this forum gathered many heavyweight guests from fields such as pharmaceutical industry, pharmaceutical commerce, chain pharmacies, and pharmaceutical R&D to explore cutting-edge development technologies and directions in the industry and seek the future development of the pharmaceutical and health industry.
The honors obtained by Leadingpharm this time are not only a recognition of its efforts in the field of pharmaceutical R&D over the past year, but also an affirmation of its long-term adherence to innovation and integrity in operation. Looking forward to the future, Leadingpharm will continue to commit itself to technological innovation and product R&D, improve clinical service levels, accelerate the transformation of innovative achievements, and constantly enhance the core competitiveness of the enterprise. At the same time, Leadingpharm will also actively fulfill its social responsibilities and make greater contributions to promoting the high-quality development of the pharmaceutical and health industry.
The Taishan Pharmaceutical Forum, as an authoritative event in the pharmaceutical industry, aims to gather industry elites to discuss the development trends and future opportunities of the pharmaceutical and health industry. With the theme of "All-Industry · Big Platform · Deep Integration · Common Development", this forum gathered many heavyweight guests from fields such as pharmaceutical industry, pharmaceutical commerce, chain pharmacies, and pharmaceutical R&D to explore cutting-edge development technologies and directions in the industry and seek the future development of the pharmaceutical and health industry.
The honors obtained by Leadingpharm this time are not only a recognition of its efforts in the field of pharmaceutical R&D over the past year, but also an affirmation of its long-term adherence to innovation and integrity in operation. Looking forward to the future, Leadingpharm will continue to commit itself to technological innovation and product R&D, improve clinical service levels, accelerate the transformation of innovative achievements, and constantly enhance the core competitiveness of the enterprise. At the same time, Leadingpharm will also actively fulfill its social responsibilities and make greater contributions to promoting the high-quality development of the pharmaceutical and health industry.
-END-
轉(zhuǎn)載聲明：未經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)，不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)使用作品的，應(yīng)在授權(quán)范圍內(nèi)使用，并注明“來(lái)源：新領(lǐng)先醫(yī)藥科技”。
010-83057670
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
